Literature DB >> 22098494

Cyclic hydroxyamidines as amide isosteres: discovery of oxadiazolines and oxadiazines as potent and highly efficacious γ-secretase modulators in vivo.

Zhong-Yue Sun1, Theodros Asberom, Thomas Bara, Chad Bennett, Duane Burnett, Inhou Chu, John Clader, Mary Cohen-Williams, David Cole, Michael Czarniecki, James Durkin, Gioconda Gallo, William Greenlee, Hubert Josien, Xianhai Huang, Lynn Hyde, Nicholas Jones, Irina Kazakevich, Hongmei Li, Xiaoxiang Liu, Julie Lee, Malcolm Maccoss, Mihir B Mandal, Troy McCracken, Amin Nomeir, Robert Mazzola, Anandan Palani, Eric M Parker, Dmitri A Pissarnitski, Jun Qin, Lixin Song, Giuseppe Terracina, Monica Vicarel, Johannes Voigt, Ruo Xu, Lili Zhang, Qi Zhang, Zhiqiang Zhao, Xiaohong Zhu, Zhaoning Zhu.   

Abstract

Cyclic hydroxyamidines were designed and validated as isosteric replacements of the amide functionality. Compounds with these structural motifs were found to be metabolically stable and to possess highly desirable pharmacokinetic profiles. These designs were applied in the identification of γ-secretase modulators leading to highly efficacious agents for reduction of central nervous system Aβ(42) in various animal models.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22098494     DOI: 10.1021/jm201407j

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

1.  Discovery of SCH 900229, a Potent Presenilin 1 Selective γ-Secretase Inhibitor for the Treatment of Alzheimer's Disease.

Authors:  Wen-Lian Wu; Martin Domalski; Duane A Burnett; Hubert Josien; Thomas Bara; Murali Rajagopalan; Ruo Xu; John Clader; William J Greenlee; Andrew Brunskill; Lynn A Hyde; Robert A Del Vecchio; Mary E Cohen-Williams; Lixin Song; Julie Lee; Giuseppe Terracina; Qi Zhang; Amin Nomeir; Eric M Parker; Lili Zhang
Journal:  ACS Med Chem Lett       Date:  2012-04-09       Impact factor: 4.345

2.  Synthesis and SAR Studies of Fused Oxadiazines as γ-Secretase Modulators for Treatment of Alzheimer's Disease.

Authors:  Xianhai Huang; Wei Zhou; Xiaoxiang Liu; Hongmei Li; George Sun; Mihirbaran Mandal; Monica Vicarel; Xiaohong Zhu; Chad Bennett; Troy McCraken; Dmitri Pissarnitski; Zhiqiang Zhao; David Cole; Gioconda Gallo; Zhaoning Zhu; Anandan Palani; Robert Aslanian; John Clader; Michael Czarniecki; William Greenlee; Duane Burnett; Mary Cohen-Williams; Lynn Hyde; Lixin Song; Lili Zhang; Inhou Chu; Alexei Buevich
Journal:  ACS Med Chem Lett       Date:  2012-09-04       Impact factor: 4.345

Review 3.  γ-Secretase inhibitors and modulators.

Authors:  Todd E Golde; Edward H Koo; Kevin M Felsenstein; Barbara A Osborne; Lucio Miele
Journal:  Biochim Biophys Acta       Date:  2013-06-17

Review 4.  Recent developments of small molecule γ-secretase modulators for Alzheimer's disease.

Authors:  Shekar Mekala; Grady Nelson; Yue-Ming Li
Journal:  RSC Med Chem       Date:  2020-08-27

Review 5.  Development and mechanism of γ-secretase modulators for Alzheimer's disease.

Authors:  Christina J Crump; Douglas S Johnson; Yue-Ming Li
Journal:  Biochemistry       Date:  2013-05-02       Impact factor: 3.162

6.  Discovery of a Tetrahydrobenzisoxazole Series of γ-Secretase Modulators.

Authors:  Zhiqiang Zhao; Dmitri A Pissarnitski; Xianhai Huang; Anandan Palani; Zhaoning Zhu; William J Greenlee; Lynn A Hyde; Lixin Song; Giuseppe Terracina; Lili Zhang; Eric M Parker
Journal:  ACS Med Chem Lett       Date:  2017-09-19       Impact factor: 4.345

Review 7.  Structural and Chemical Biology of Presenilin Complexes.

Authors:  Douglas S Johnson; Yue-Ming Li; Martin Pettersson; Peter H St George-Hyslop
Journal:  Cold Spring Harb Perspect Med       Date:  2017-12-01       Impact factor: 6.915

8.  γ-Secretase Modulators: Can We Combine Potency with Safety?

Authors:  Harrie J M Gijsen; Marc Mercken
Journal:  Int J Alzheimers Dis       Date:  2012-12-17

9.  Identification and Preclinical Pharmacology of the γ-Secretase Modulator BMS-869780.

Authors:  Jeremy H Toyn; Lorin A Thompson; Kimberley A Lentz; Jere E Meredith; Catherine R Burton; Sethu Sankaranararyanan; Valerie Guss; Tracey Hall; Lawrence G Iben; Carol M Krause; Rudy Krause; Xu-Alan Lin; Maria Pierdomenico; Craig Polson; Alan S Robertson; R Rex Denton; James E Grace; John Morrison; Joseph Raybon; Xiaoliang Zhuo; Kimberly Snow; Ramesh Padmanabha; Michele Agler; Kim Esposito; David Harden; Margaret Prack; Sam Varma; Victoria Wong; Yingjie Zhu; Tatyana Zvyaga; Samuel Gerritz; Lawrence R Marcin; Mendi A Higgins; Jianliang Shi; Cong Wei; Joseph L Cantone; Dieter M Drexler; John E Macor; Richard E Olson; Michael K Ahlijanian; Charles F Albright
Journal:  Int J Alzheimers Dis       Date:  2014-07-08

Review 10.  Targeting Amyloidogenic Processing of APP in Alzheimer's Disease.

Authors:  Jing Zhao; Xinyue Liu; Weiming Xia; Yingkai Zhang; Chunyu Wang
Journal:  Front Mol Neurosci       Date:  2020-08-04       Impact factor: 5.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.